BioSpace News Archive

A groundbreaking in vivo clinical study conducted by Dr. Richard Horowitz, serving on the U.S. Department of Health and Human Services Babesia and Tick-borne Pathogens subcommittee, has found that an eight-week course of the proven leprosy drug dapsone combined with doxycycline and rifampin is effective in improving symptoms in 98% of patients suffering from chronic Lyme disease/Post Treatment Lyme Disease Syndrome (PTLDS).

AMRA’s research, in collaboration with Linköping University, proposes a standardized muscle-specific metric using magnetic resonance imaging (MRI) to detect a vulnerable muscle phenotype within non-alcoholic fatty liver disease (NAFLD) and recommends strengthening of future sarcopenia guidelines by the introduction of cut-off values for muscle fat.

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today provided an update on its preclinical work on its next-generation chemotherapeutic, DHA-dFdC, and the solid lipid nanoparticle (SLN) drug delivery system to treat pancreatic cancer

Premier Medical Laboratory Services (PMLS), an award winning molecular diagnostics laboratory, introduces Virtual Lab, an innovative COVID-19 testing solution to overcome laboratory infrastructure restrictions

Cerner Corporation (Nasdaq: CERN) today announced results for the 2020 third quarter that ended September 30, 2020.

The World Health Organization announced in this week’s WHO Weekly Epidemiological Record that Malawi has been validated to have eliminated lymphatic filariasis as a public health problem.

ChemoCentryx, Inc., (Nasdaq: CCXI), today announced positive topline data from the Company’s AURORA randomized, double-blind, placebo-controlled, multi-center Phase II clinical trial of avacopan for the treatment of the chronic disabling skin disease Hidradenitis Suppurativa (HS)

Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2020.

Curemark, is pleased to announce the appointment of Leigh Morgan of Seattle, WA to its Board of Directors.

3M today is announcing the availability of PREVENA RESTOR AXIO•FORM™ Incision Management System, designed to manage post-operative incisions, as well as the surrounding soft tissue envelope, following the orthopedic surgical repair of lower extremity fractures.